Growth Metrics

Adaptive Biotechnologies (ADPT) Treasury Shares (2019 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Treasury Shares for 7 consecutive years, with $11.2 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 10.52% to $11.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.2 million through Dec 2025, up 10.52% year-over-year, with the annual reading at $11.2 million for FY2025, 10.52% up from the prior year.
  • Treasury Shares hit $11.2 million in Q4 2025 for Adaptive Biotechnologies, up from $5.4 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $12.0 million in Q1 2024 to a low of $651649.0 in Q1 2021.
  • Historically, Treasury Shares has averaged $6.0 million across 5 years, with a median of $5.5 million in 2022.
  • Biggest five-year swings in Treasury Shares: soared 28862.18% in 2021 and later tumbled 82.17% in 2024.
  • Year by year, Treasury Shares stood at $1.2 million in 2021, then skyrocketed by 393.87% to $6.0 million in 2022, then tumbled by 68.02% to $1.9 million in 2023, then skyrocketed by 431.97% to $10.2 million in 2024, then grew by 10.52% to $11.2 million in 2025.
  • Business Quant data shows Treasury Shares for ADPT at $11.2 million in Q4 2025, $5.4 million in Q3 2025, and $11.6 million in Q2 2025.